NCT00501267View on ClinicalTrials.gov

A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Overactive Bladder

Interventions

DRUG

solabegron and oxybutynin

Trial Locations (1)

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY